Developmental history of the extent of lymph node dissection in pancreatic cancer surgery
-
摘要: 胰腺癌是所有消化系统恶性肿瘤中患者预后情况最差的之一,总体5年生存率仅约5%,即使进行了根治性切除,患者5年生存率也仅为20%左右。复发和转移是影响胰腺癌患者术后生存的最关键因素,其中易发生淋巴结转移是胰腺癌的重要特点,因而淋巴结的清扫范围一直是胰腺癌根治术的一个热点问题。对胰腺癌根治术淋巴结清扫范围的历史与现状进行了总结,认为规范化的淋巴结清扫是改善胰腺癌术后患者预后的关键因素之一。Abstract: Pancreatic cancer is one of the digestive malignant tumors with the worst prognosis and has an overall 5- year survival rate as low as 5%. Even though radical resection is performed,the 5- year survival rate is only about 20%. Recurrence and metastasis are the most important influencing factors for the postoperative survival of patients with pancreatic cancer. Lymph node metastasis is an important feature of pancreatic cancer,and the extent of lymph node dissection has always been a hot topic in radical surgery for pancreatic cancer. This article summarizes the history and current status of the extent of lymph node dissection in pancreatic cancer and points out that standardized lymph node dissection is a key factor for improving patients' prognosis after pancreatic cancer surgery.
-
Key words:
- pancreatic neoplasms /
- lymph node excision /
- surgical procedures
-
[1]SIEGEL R,NAISHADHAM D,JEMAL A.Cancer statistics,2013[J].CA Cancer J Clin,2013,63(1):11-30. [2]CHEN W,ZHENG R,BAADE PD,et al.Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. [3]ANDRIULLI A,FESTA V,BOTTERI E,et al.Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer:a meta-analysis of prospective studies[J].Ann Surg Oncol,2012,19(5):1644-1662. [4]DAVIS JL,PANDALAI PK,RIPLEY RT,et al.Expanding surgical treatment of pancreatic cancer:the role of regional chemotherapy[J].Pancreas,2012,41(5):678-684. [5]DRAGOVICH T.Is there a case for personalized therapy of pancreatic cancer?[J].Clin Adv Hematol Oncol,2012,10(5):344-345. [6]PORUK KE,FIRPO MA,ADLER DG,et al.Screening for pancreatic cancer:why,how,and who?[J].Ann Surg,2013,257(1):17-26. [7]HARTWIG W,VOLLMER CM,FINGERHUT A,et al.Extended pancreatectomy in pancreatic ductal adenocarcinoma:definition and consensus of the International Study Group for Pancreatic Surgery(ISGPS)[J].Surgery,2014,156(1):1-14. [8]Japan Pancreas Society.General rules for cancer of the pancreas[M].3rd ed.Tokyo:Kanehara Shuppan,1986. [9]ISHIKAWA O,OHHIGASHI H,SASAKI Y,et al.Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head[J].Ann Surg,1988,208(2):215-220. [10]MANABE T,OHSHIO G,BABA N,et al.Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas[J].Cancer,1989,64(5):1132-1137. [11]HENNE-BRUNS D,VOGEL I,LTTGES J,et al.Ductal adenocarcinoma of the pancreas head:survival after regional versus extended lymphadenectomy[J].Hepatogastroenterology,1998,45(21):855-866. [12]MUKAIYA M,HIRATA K,SATOH T,et al.Lack of survival benefit of extended lymph node dissection for ductal adenocarcinoma of the head of the pancreas:retrospective multi-institutional analysis in Japan[J].World J Surg,1998,22(3):248-252. [13]YEO CJ,BASTIDAS JA,SCHMIEG RE Jr,et al.Pancreatic structure and glucose tolerance in a longitudinal study of experimental pancreatitis-induced diabetes[J].Ann Surg,1989,210(2):150-158. [14]YEO CJ,CAMERON JL,LILLEMOE KD,et al.Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma,part 2:randomized controlled trial evaluating survival,morbidity,and mortality[J].Ann Surg,2002,236(3):355-366. [15]PEDRAZZOLI S,DICARLO V,DIONIGI R,et al.Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas:a multicenter,prospective,randomized study.Lymphadenectomy Study Group[J].Ann Surg,1998,228(4):508-517. [16]POPIELA T,KEDRA B,SIERZEGA M,et al.Does extended lymphadenectomy improve survival of pancreatic cancer patients?[J].Acta Chir Belg,2002,102(2):78-82. [17]FARNELL MB,PEARSON RK,SARR MG,et al.A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma[J].Surgery,2005,138(4):618-628. [18]Japan Pancreas Society.Classification of pancreatic carcinoma[M].2nd English ed.Tokyo:Kanehara Shuppan,2003. [19]TEMPERO MA,MALAFA MP,BEHRMAN SW,et al.Pancreatic adenocarcinoma,version 2.2014:featured updates to the NCCN guidelines[J].J Natl Compr Canc Netw,2014,12(8):1083-1093. [20]TOL JA,GOUMA DJ,BASSI C,et al.Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma:a consensus statement by the International Study Group on Pancreatic Surgery(ISGPS)[J].Surgery,2014,156(3):591-600. [21]CONNOR S,BOSONNET L,GHANEH P,et al.Survival of patients with periampullary carcinoma is predicted by lymph node 8a but not by lymph node 16b1 status[J].Br J Surg,2004,91(12):1592-1599. [22] Group of Pancreas Surgery,Chinese Society of Surgery,Chinese Medical Association.Guidelines for the management of pancreatic cancer(2014)[J].J Clin Hepatol,2014,30(12):1240-1245.(in Chinese)中华医学会外科学分会胰腺外科学组.胰腺癌诊治指南(2014)[J].临床肝胆病杂志,2014,30(12):1240-1245. [23]PAIELLA S,SANDINI M,GIANOTTI L,et al.The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer:a systematic review and meta-analysis[J].Eur J Surg Oncol,2016,42(5):616-624. [24]KAWABATA Y,TANAKA T,ISHIKAWA N,et al.Modified total meso-pancreatoduodenum excision with pancreaticoduodenectomy as a mesopancreatic plane surgery in borderline resectable pancreatic cancer[J].Eur J Surg Oncol,2016,42(5):698-705.
本文二维码
计量
- 文章访问数: 2899
- HTML全文浏览量: 40
- PDF下载量: 475
- 被引次数: 0